Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis
Launched by MANHATTAN PHYSICAL MEDICINE AND REHABILITATION, LLP · Jun 5, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the combination of botulinum toxin injections and yoga-like exercises to help improve scoliosis in teenagers. Scoliosis is a condition where the spine curves to the side, and this study focuses on adolescents who have a curve between 25 and 45 degrees. The researchers believe that using both the injections and specific yoga poses could help reduce these curves. While previous studies have shown that yoga poses can be effective, this is the first study to look at how they work together with botulinum toxin.
To participate in this trial, you need to be between 14 and 18 years old and have scoliosis with a curve that meets the criteria. It’s important that you can commit to doing the yoga exercises daily and that you have written consent from a parent or guardian. Participants will have regular check-ins and will receive both the injections and guidance on the yoga-like exercises. If you have certain medical conditions or have previously received botulinum toxin, you may not be eligible. This trial is currently recruiting participants of all genders, and it aims to provide more options for managing scoliosis effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Fourteen - 18 years of age, 2. Scoliotic curve greater than 25 degrees, less than 45 degrees, 3. Stated willingness to do the yoga and yoga-like poses daily, 4. Written, signed consent by patient and parent/guardian 5. Pre-test Cobb films no less than 3 months old read by independent radiologists.
- * Exclusion Criteria:
- • 1. Neurological, muscular or neuromuscular disease, (e.gs., cerebral palsy, myopathy, stroke),
- • 2. Genetic abnormalities that affect limb growth, proportionality or metabolism, (e.gs., mucopolysaccharidoses, Marfan's syndrome, Refsums disease).
- • 3. Pregnancy and other conditions prohibiting X-rays or minute(s)-long exertion (e.gs., congestive heart failure, great weakness, COPD).
- • 4. Previous exposure to botulinum neurotoxin Type A. Sexually active female subjects must present a recent negative pregnancy test.
About Manhattan Physical Medicine And Rehabilitation, Llp
Manhattan Physical Medicine and Rehabilitation, LLP is a leading clinical trial sponsor dedicated to advancing the field of rehabilitation medicine through innovative research and evidence-based practices. Committed to improving patient outcomes, the organization specializes in conducting high-quality clinical trials that focus on musculoskeletal disorders, pain management, and functional recovery. With a multidisciplinary team of experienced professionals, Manhattan Physical Medicine and Rehabilitation fosters collaboration and rigor in its research efforts, ensuring that new therapies are thoroughly evaluated for safety and efficacy. The organization aims to contribute significantly to the development of effective treatment modalities that enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manhattan, New York, United States
Patients applied
Trial Officials
Loren M Fishman
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials